148 related articles for article (PubMed ID: 25448606)
1. Role of miRNAs in endometrial cancer.
Li S; Zhang J; Wan X
Histol Histopathol; 2015 May; 30(5):539-48. PubMed ID: 25448606
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
[TBL] [Abstract][Full Text] [Related]
3. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.
Zheng Y; Yang X; Wang C; Zhang S; Wang Z; Li M; Wang Y; Wang X; Yang X
Sci Rep; 2020 Feb; 10(1):3576. PubMed ID: 32107418
[TBL] [Abstract][Full Text] [Related]
4. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
Zhang H; Wang X; Chen Z; Wang W
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent CN; Guttilla Reed IK
Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
[TBL] [Abstract][Full Text] [Related]
7. [The role of miRNA in endometrial cancer in the context of miRNA 205].
Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
[TBL] [Abstract][Full Text] [Related]
8. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
[TBL] [Abstract][Full Text] [Related]
9. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.
Zhang J; Yang Y; Zhang Z; He Y; Liu Z; Yu Y; Wu S; Cai B; Feng Y
Cancer Lett; 2013 Oct; 339(2):279-87. PubMed ID: 23142288
[TBL] [Abstract][Full Text] [Related]
10. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Hu M; Zhu S; Xiong S; Xue X; Zhou X
Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
[TBL] [Abstract][Full Text] [Related]
13. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.
Abadi AJ; Zarrabi A; Gholami MH; Mirzaei S; Hashemi F; Zabolian A; Entezari M; Hushmandi K; Ashrafizadeh M; Khan H; Kumar AP
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670518
[TBL] [Abstract][Full Text] [Related]
14. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
15. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
[TBL] [Abstract][Full Text] [Related]
16. ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer.
Tran DN; Rozen V; Nguyen LTK; Jung JS; Coghill LM; Hunter MI; Kim TH; Yoo JY; Jeong JW
Reprod Sci; 2024 Jun; 31(6):1632-1641. PubMed ID: 38388922
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
18. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
[TBL] [Abstract][Full Text] [Related]
19. Serum Prolactin Contributes to Enhancing Prolactin Receptor and pJAK2 in Type I Endometrial Cancer Cells in Young Women Without Insulin Resistance.
Erdenebaatar C; Yamaguchi M; Monsur M; Saito F; Honda R; Tashiro H; Ohba T; Iyama KI; Katabuchi H
Int J Gynecol Pathol; 2019 Jul; 38(4):318-325. PubMed ID: 29901521
[TBL] [Abstract][Full Text] [Related]
20. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
